BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 38462755)

  • 21. Migrant men and HIV care engagement in Johannesburg, South Africa.
    Nardell MF; Govathson C; Mngadi-Ncube S; Ngcobo N; Letswalo D; Lurie M; Miot J; Long L; Katz IT; Pascoe S
    BMC Public Health; 2024 Feb; 24(1):435. PubMed ID: 38347453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA; Dada S; Martin CE; Mullick S
    J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceptions of Pre-exposure Prophylaxis (PrEP) for HIV prevention among men living with HIV in the context of reproductive goals in South Africa: a qualitative study.
    Ntinga X; Isehunwa OO; Msimango LI; Smith PM; Matthews LT; Van Heerden A
    BMC Public Health; 2024 Feb; 24(1):553. PubMed ID: 38389039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South Africa.
    Grammatico MA; Moll AP; Choi K; Springer SA; Shenoi SV
    J Int AIDS Soc; 2021 Nov; 24(11):e25848. PubMed ID: 34826363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The South African community pharmacy sector-an untapped reservoir for delivering HIV services.
    Nyamuzihwa T; Tembo A; Martyn N; Venter F; Maimin J; Houghton J; Lalla-Edward ST
    Front Reprod Health; 2023; 5():1173576. PubMed ID: 37519342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving access to oral pre-exposure prophylaxis for HIV among international migrant populations.
    Tieosapjaroen W; Zhang Y; Fairley CK; Zhang L; Chow EPF; Phillips TR; Schmidt HM; Bavinton BR; O'Donnell D; Mao L; Grulich A; Ong JJ
    Lancet Public Health; 2023 Aug; 8(8):e651-e658. PubMed ID: 37421969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of migration and implications for health in government policy of South Africa.
    Manji K; Perera S; Hanefeld J; Vearey J; Olivier J; Gilson L; Walls H
    Int J Equity Health; 2023 May; 22(1):82. PubMed ID: 37158907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.
    Chen Y; Saldarriaga EM; Montano MA; Ngure K; Thuo N; Kiptinness C; Rafferty M; Terris-Prestholt F; Stergachis A; Mugambi ML; Ortblad KF; Sharma M
    BMJ Open; 2023 Apr; 13(4):e069195. PubMed ID: 37012008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers and facilitators to oral PrEP uptake among high-risk men after HIV testing at workplaces in Uganda: a qualitative study.
    Nabunya R; Karis VMS; Nakanwagi LJ; Mukisa P; Muwanguzi PA
    BMC Public Health; 2023 Feb; 23(1):365. PubMed ID: 36805698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilizing Soccer for Delivery of HIV and Substance Use Prevention for Young South African Men: 6-Month Outcomes of a Cluster Randomized Controlled Trial.
    Rabie S; Tomlinson M; Almirol E; Stewart J; Skiti Z; Weiss RE; Vogel L; Rotheram-Borus MJ
    AIDS Behav; 2023 Mar; 27(3):842-854. PubMed ID: 36380117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
    Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
    J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya.
    Katz IT; Ngure K; Kamolloh K; Ogello V; Okombo M; Thuo NB; Owino E; Garrison LE; Lee YS; Nardell MF; Anyacheblu C; Bukusi E; Mugo N; Baeten JM; Haberer JE;
    AIDS Behav; 2023 Jan; 27(1):106-118. PubMed ID: 35930203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HIV Epidemic in South Africa: Key Findings from 2017 National Population-Based Survey.
    Zuma K; Simbayi L; Zungu N; Moyo S; Marinda E; Jooste S; North A; Nadol P; Aynalem G; Igumbor E; Dietrich C; Sigida S; Chibi B; Makola L; Kondlo L; Porter S; Ramlagan S; On Behalf Of The Sabssm V Study Group Contributors
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Human Rights Case Study on Access to Pre-exposure Prophylaxis for Female Sex Workers in South Africa.
    Winkelman S
    Health Hum Rights; 2022 Jun; 24(1):105-115. PubMed ID: 35747274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Men missing from the HIV care continuum in sub-Saharan Africa: a meta-analysis and meta-synthesis.
    Nardell MF; Adeoti O; Peters C; Kakuhikire B; Govathson-Mandimika C; Long L; Pascoe S; Tsai AC; Katz IT
    J Int AIDS Soc; 2022 Mar; 25(3):e25889. PubMed ID: 35324089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacist-initiated antiretroviral therapy (PIMART).
    Moodley S; Gray A; Schellack N; Schellack N; Venter F; Venter F; Suleman F; Suleman F; Walker RB; Walker RB; Choonara Y; Choonara Y; Truter I; Truter I; Maimin J; Maimin J; Malan SF; Malan SF; Hattingh J; Hattingh J; Meyer JC; Meyer JC; Demana P; Demana P; Kotzé I; Kotzé I; Kubashe N; Kubashe N; Komape TK; Komape TK; Van Wyk S; Van Wyk S; Eksteen M; Eksteen M
    S Afr Med J; 2021 Dec; 111(12):1162-1163. PubMed ID: 34949299
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations - Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine.
    Rousseau E; Julies RF; Madubela N; Kassim S
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):500-507. PubMed ID: 34708316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the impact of exposure to adverse socioeconomic conditions on chronic stress from a complexity science perspective.
    Crielaard L; Nicolaou M; Sawyer A; Quax R; Stronks K
    BMC Med; 2021 Oct; 19(1):242. PubMed ID: 34635083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
    BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.